SEC Form 4 · accession 0000899243-18-019367
Translate Bio, Inc. · TBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald C Renaud Jr.
Officer — See Remarks · Director
Period of report
Jul 2, 2018
Accepted (ET)
Jul 3, 2018 · 8:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001693415
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 2, 2018 | C | 40,909 | — | A | 409,913 | I | By Ronald Renaud 2014 Irrevocable Family Trust |
| Common StockF1 | Jul 2, 2018 | C | 40,909 | — | A | 40,909 | I | By Ronald C. Renaud, Jr. Trust - 2007 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series C Preferred StockF1 | — | Jul 2, 2018 | C | 227,272 | D | — | — | Common Stock | 40,909 | 0 | I |
| Series C Preferred StockF1 | — | Jul 2, 2018 | C | 227,272 | D | — | — | Common Stock | 40,909 | 0 | I |
Explanation of responses
- F1The Series C Preferred Stock converted into Common Stock on a 5.5555-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.
Remarks
President and Chief Executive Officer